{"PubmedArticle": [{"MedlineCitation": {"InvestigatorList": [], "SpaceFlightMission": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "OtherID": [], "PMID": "16671794", "DateCompleted": {"Year": "2007", "Month": "02", "Day": "15"}, "DateRevised": {"Year": "2018", "Month": "12", "Day": "01"}, "Article": {"Language": ["eng"], "ELocationID": [], "ArticleDate": [], "Journal": {"ISSN": "1523-7060", "JournalIssue": {"Volume": "8", "Issue": "10", "PubDate": {"Year": "2006", "Month": "May", "Day": "11"}}, "Title": "Organic letters", "ISOAbbreviation": "Org Lett"}, "ArticleTitle": "A new approach to the furan degradation problem involving ozonolysis of the trans-enedione and its use in a cost-effective synthesis of eplerenone.", "Pagination": {"StartPage": "2111", "EndPage": "2113", "MedlinePgn": "2111-3"}, "Abstract": {"AbstractText": ["[reaction: see text] Whereas ozonization of furan 3a affords little or no carboxylic acid 5, ozonization of the corresponding trans-enedione 6 afforded carboxylic acid 5 in 82.4% yield (cryst., overall from furan, 100 g scale; after workup with dimethyl sulfide, followed by mildly basic hydrogen peroxide). This new approach to furan degradation is showcased in a cost-effective synthesis of eplerenone, an important new medicine for cardiovascular indications."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Chemical Research and Development, Pfizer, Incorporated, Kalamazoo, Michigan 49001-0102, USA. bruce.pearlman@spcorp.com"}], "Identifier": [], "LastName": "Pearlman", "ForeName": "Bruce A", "Initials": "BA"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Padilla", "ForeName": "Amphlett G", "Initials": "AG"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Hach", "ForeName": "John T", "Initials": "JT"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Havens", "ForeName": "Jeffrey L", "Initials": "JL"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Pillai", "ForeName": "Muniraj D", "Initials": "MD"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Org Lett", "NlmUniqueID": "100890393", "ISSNLinking": "1523-7052"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Furans"}, {"RegistryNumber": "27O7W4T232", "NameOfSubstance": "Spironolactone"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}, {"RegistryNumber": "6995V82D0B", "NameOfSubstance": "Eplerenone"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Catalysis"}, {"QualifierName": [], "DescriptorName": "Eplerenone"}, {"QualifierName": ["chemistry"], "DescriptorName": "Furans"}, {"QualifierName": [], "DescriptorName": "Molecular Structure"}, {"QualifierName": ["chemistry"], "DescriptorName": "Ozone"}, {"QualifierName": ["analogs & derivatives", "chemical synthesis", "economics"], "DescriptorName": "Spironolactone"}, {"QualifierName": [], "DescriptorName": "Stereoisomerism"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2006", "Month": "5", "Day": "5", "Hour": "9", "Minute": "0"}, {"Year": "2007", "Month": "2", "Day": "16", "Hour": "9", "Minute": "0"}, {"Year": "2006", "Month": "5", "Day": "5", "Hour": "9", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["16671794", "10.1021/ol060503v"]}}], "PubmedBookArticle": []}